Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Ertapenem in Complicated Intra-abdominal Infections
NCT00492726Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2006
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial of moxifloxacin in Intra-abdominal infection (IAI) (2 arms), sponsored by Bayer. Primary endpoint: Clinical Cure at Test of Cure (TOC) Visit. Started Jul 2006; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00492726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492726.